Found 717 matching trials
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer NA Clinicians are currently proposing second-line hormonal treatment to a meta...
Show More Location
Institut de Cancerologie de l'Ouest
Learn More & Join Trial
Denosumab and MRI Breast Imaging PHASE2 This is a non-randomized phase II trial of denosumab at 120 mg subcutaneous...
Show More Location
Stony Brook University Cancer Center
Learn More & Join Trial
Diagnostic Accuracy of Carebot AI MMG in Mammography Screening: Multicenter MRMC Study N/A This study evaluates the diagnostic performance of Carebot AI MMG, an artif...
Show More Location
Poliklinika MEDICON Budějovická
Learn More & Join Trial
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer NA RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Risk-Based Breast Screening in Young Women NA The RIBBS study is a single-arm single-center study that aims to evaluate t...
Show More Location
Istituto Oncologico Veneto (IRCCS)
Learn More & Join Trial
Histology of Functional Density in Postmenopausal Breast N/A Increased mammographic density is recognized as an important risk factor fo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities N/A This is a study looking at advanced imaging such as PET/CT and MRI to see i...
Show More Location
Central New York PET Center
Learn More & Join Trial
Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients N/A The purpose of this study is to better understand why some women with breas...
Show More Location
University of Michigan Comprehensive Cancer Center
Learn More & Join Trial
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer PHASE1 The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Show More Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Learn More & Join Trial
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 NA RATIONALE: Gathering information over time from bone density and laboratory...
Show More Location
Royal Brisbane and Women's Hospital
Learn More & Join Trial